N-Acetyl Cysteine (NAC) in the Treatment of Obsessive-Compulsive Disorder: A 16-Week, Double-Blind, Randomised, Placebo-Controlled Study

Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review

(2015) Deepmala et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

N-Acetyl Cysteine in the Treatment of Obsessive Compulsive and Related Disorders: A Systematic Review

(2015) Georgina Oliver et al.   Clinical Psychopharmacology and Neuroscience

Brief Report: Attention Deficit and Hyperactivity Disorder Scores Are Elevated and Respond toN-Acetylcysteine Treatment in Patients With Systemic Lupus Erythematosus

(2013) Ricardo J. Garcia et al.   ARTHRITIS AND RHEUMATISM

Obsessive compulsive disorder and the glutamatergic system

(2013) Catherine Kariuki-Nyuthe et al.   CURRENT OPINION IN PSYCHIATRY

Repeated Cortico-Striatal Stimulation Generates Persistent OCD-Like Behavior

(2013) S. E. Ahmari et al.   SCIENCE

The promise of N-acetylcysteine in neuropsychiatry

(2013) Michael Berk et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Brain Corticostriatal Systems and the Major Clinical Symptom Dimensions of Obsessive-Compulsive Disorder

(2012) Ben J. Harrison et al.   BIOLOGICAL PSYCHIATRY

N-Acetylcysteine Add-On Treatment in Refractory Obsessive-Compulsive Disorder

(2012) Hamid Afshar et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Neurobiology of obsessive–compulsive disorder: insights into neural circuitry dysfunction through mouse genetics

(2011) Jonathan T Ting et al.   CURRENT OPINION IN NEUROBIOLOGY

Glutamate abnormalities in obsessive compulsive disorder: Neurobiology, pathophysiology, and treatment

(2011) Christopher Pittenger et al.   PHARMACOLOGY & THERAPEUTICS

The role of glutamate signaling in the pathogenesis and treatment of obsessive–compulsive disorder

(2011) Ke Wu et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways

(2011) Mohammed R. Milad et al.   TRENDS IN COGNITIVE SCIENCES

Effects of N-acetyl-cysteine treatment on glutathione depletion and a short-term spatial memory deficit in 2-cyclohexene-1-one-treated rats

(2010) Kwok Ho Christopher Choy et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Relationship of Possible Stress-Related Biochemical Markers to Oxidative/Antioxidative Status in Obsessive-Compulsive Disorder

(2010) A. Behl et al.   NEUROPSYCHOBIOLOGY

Repeated N-Acetyl Cysteine Reduces Cocaine Seeking in Rodents and Craving in Cocaine-Dependent Humans

(2010) Shelley L Amen et al.   NEUROPSYCHOPHARMACOLOGY

N-Acetylcysteine, a Glutamate Modulator, in the Treatment of Trichotillomania

(2009) Jon E. Grant et al.   ARCHIVES OF GENERAL PSYCHIATRY

Anterior Cingulate Glutamate–Glutamine Levels Predict Symptom Severity in Women With Obsessive–Compulsive Disorder

(2009) Murat Yücel et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Anatomical Alterations and Symptom-Related Functional Activity in Obsessive-Compulsive Disorder Are Correlated in the Lateral Orbitofrontal Cortex

(2009) Jean-Yves Rotge et al.   BIOLOGICAL PSYCHIATRY

Anti-Brain Autoantibodies and Altered Excitatory Neurotransmitters in Obsessive–Compulsive Disorder

(2009) Sagnik Bhattacharyya et al.   NEUROPSYCHOPHARMACOLOGY

Correlation between lipid peroxidation-induced TBARS level and disease severity in obsessive–compulsive disorder

(2009) Sutirtha Chakraborty et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

N-Acetyl Cysteine for Depressive Symptoms in Bipolar Disorder—A Double-Blind Randomized Placebo-Controlled Trial

(2008) Michael Berk et al.   BIOLOGICAL PSYCHIATRY

N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial

(2008) Michael Berk et al.   BIOLOGICAL PSYCHIATRY

Meta-Analysis of Brain Volume Changes in Obsessive-Compulsive Disorder

(2008) Jean-Yves Rotge et al.   BIOLOGICAL PSYCHIATRY

The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication

(2008) A M Ruscio et al.   MOLECULAR PSYCHIATRY

Serum selenium and plasma malondialdehyde levels and antioxidant enzyme activities in patients with obsessive–compulsive disorder

(2008) Ercan Ozdemir et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY